Insider Transactions in Q2 2024 at Geron Corp (GERN)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2024
|
Robert J. Spiegel |
SELL
Grant, award, or other acquisition
|
Direct |
1,916
-1.12%
|
-
|
|
Jun 10
2024
|
Anil Kapur EVP, Corp Strategy & CCO |
SELL
Open market or private sale
|
Direct |
421,875
-100.0%
|
$1,687,500
$4.64 P/Share
|
|
Jun 10
2024
|
Anil Kapur EVP, Corp Strategy & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
421,875
+50.0%
|
$421,875
$1.06 P/Share
|
|
Jun 10
2024
|
Faye Feller EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
287,900
-100.0%
|
$1,151,600
$4.63 P/Share
|
|
Jun 10
2024
|
Faye Feller EVP, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
287,900
+50.0%
|
$287,900
$1.14 P/Share
|
|
Jun 04
2024
|
John A Scarlett Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
600,000
-50.0%
|
$2,400,000
$4.0 P/Share
|
|
Jun 04
2024
|
John A Scarlett Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
600,000
+50.0%
|
$1,200,000
$2.54 P/Share
|
|
May 15
2024
|
V Bryan Lawlis |
SELL
Open market or private sale
|
Direct |
35,000
-100.0%
|
$105,000
$3.75 P/Share
|
|
May 15
2024
|
V Bryan Lawlis |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+50.0%
|
$35,000
$1.94 P/Share
|